/ Print /

Pharmacy Strategy

Seven barriers to prescribing PCSK9 inhibitorsThe National Lipid Association releases interesting survey results on PCSK9 inhibitors prescription approval process.
Managed Care Pharmacy Survey 2017To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2017.
Top 10 states with the worst drug problemsWalletHub released a study comparing 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to opioid prescriptions and meth-lab incidents per capita.
Two strategies to help consumers lower drug costsHealthPartners aims to improve price information for consumers. Here’s how.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Top four approaches to reduce pharmaceutical costs
Top four approaches to reduce pharmaceutical costsMCOs are fighting back against rising pharmaceutical costs. Here are the top strategies they are embracing.
Four health systems develop opioid mitigation programsAlternatives to opioids programs emerge as viable tools to mitigate the crisis.
Four ways PBMs must change to thrive in the future
Four ways PBMs must change to thrive in the futureThe days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.
Three ways technology is improving pharmacyTechnology advances in pharmacy include innovations that improve medication safety, efficiency, and patient compliance.
Value-based drug contracting shifts risk to manufacturersValue-based drug contracting between manufacturers and payers is picking up steam—appropriate timing as the healthcare industry moves toward value-based payment and purchasing and away from fee-for-service.